Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1972 1
1973 1
1974 1
1975 5
1976 11
1977 1
1978 4
1979 4
1980 3
1981 6
1982 3
1983 4
1984 5
1985 6
1986 3
1987 5
1988 11
1989 2
1990 9
1991 8
1992 10
1993 6
1994 4
1995 6
1996 6
1997 13
1998 12
1999 9
2000 9
2001 17
2002 15
2003 18
2004 20
2005 32
2006 34
2007 44
2008 35
2009 42
2010 37
2011 40
2012 49
2013 43
2014 40
2015 39
2016 72
2017 58
2018 47
2019 41
2020 50
2021 49
2022 40
2023 46
2024 18

Text availability

Article attribute

Article type

Publication date

Search Results

970 results

Results by year

Filters applied: . Clear all
Page 1
The KRASG12C Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients.
Hallin J, Engstrom LD, Hargis L, Calinisan A, Aranda R, Briere DM, Sudhakar N, Bowcut V, Baer BR, Ballard JA, Burkard MR, Fell JB, Fischer JP, Vigers GP, Xue Y, Gatto S, Fernandez-Banet J, Pavlicek A, Velastagui K, Chao RC, Barton J, Pierobon M, Baldelli E, Patricoin EF 3rd, Cassidy DP, Marx MA, Rybkin II, Johnson ML, Ou SI, Lito P, Papadopoulos KP, Jänne PA, Olson P, Christensen JG. Hallin J, et al. Among authors: aranda r. Cancer Discov. 2020 Jan;10(1):54-71. doi: 10.1158/2159-8290.CD-19-1167. Epub 2019 Oct 28. Cancer Discov. 2020. PMID: 31658955 Free PMC article.
The in-depth characterization of MRTX849 activity, elucidation of response and resistance mechanisms, and identification of effective combinations provide new insight toward KRAS dependence and the rational development of this class of agents.See related commentary by Klempner an …
The in-depth characterization of MRTX849 activity, elucidation of response and resistance mechanisms, and identification of effective combin …
Nab-Paclitaxel plus Gemcitabine and FOLFOX in Metastatic Pancreatic Cancer.
Carrato A, Pazo-Cid R, Macarulla T, Gallego J, Jiménez-Fonseca P, Rivera F, Cano MT, Rodriguez-Garrote M, Pericay C, Alés I, Layos L, Graña B, Iranzo V, Gallego I, Garcia-Carbonero R, de Mena IR, Guillén-Ponce C, Aranda E. Carrato A, et al. Among authors: aranda e. NEJM Evid. 2024 Feb;3(2):EVIDoa2300144. doi: 10.1056/EVIDoa2300144. Epub 2024 Jan 23. NEJM Evid. 2024. PMID: 38320486 Clinical Trial.
RESULTS: A total of 157 patients were randomly assigned: 78 to nab-P/Gem-mFOLFOX and 79 to nab-P/Gem. Patients receiving nab-P/Gem-mFOLFOX had a 12-month overall survival of 55.3% (95% confidence interval [CI], 44.2 to 66.5) versus 35.4% (95% CI, 24.9 to 46) …
RESULTS: A total of 157 patients were randomly assigned: 78 to nab-P/Gem-mFOLFOX and 79 to nab-P/Gem. Patients receiving nab- …
Mucopolysaccharidosis patients have reduced functional capacity.
Dias BMC, Lanza FC, Santos JD, Aranda CS, Solé D, Martins AM, Wandalsen GF. Dias BMC, et al. Among authors: aranda cs. Pediatr Pulmonol. 2022 Feb;57(2):538-543. doi: 10.1002/ppul.25750. Epub 2021 Nov 11. Pediatr Pulmonol. 2022. PMID: 34741588

The time to perform the SST was longer in the MPS group (10.6 2.5 s vs. 6.7 1.2 s; p < .01). The MPS group achieved lower values of distance covered on the ISWT (407.6 329.8 m vs. 1131.9 183.3 m; p < .01), with a significantly higher Borg (6 [5-8] vs. 2 [1-4];

…

The time to perform the SST was longer in the MPS group (10.6 2.5 s vs. 6.7 1.2 s; p < .01). The MPS group achieved lower values o

…
Peritoneal carcinomatosis in mouse models.
Arrizabalaga L, Di Trani CA, Risson A, Belsúe V, Gomar C, Ardaiz N, Berrondo P, Aranda F, Bella Á. Arrizabalaga L, et al. Among authors: aranda f. Methods Cell Biol. 2024;185:67-78. doi: 10.1016/bs.mcb.2024.02.005. Epub 2024 Mar 5. Methods Cell Biol. 2024. PMID: 38556452
Here, we describe a method to generate syngeneic PCa mouse models based on intraperitoneal (i.p.) administration of tumor cells. This model allows to follow-up cancer progression in PCa models from ovarian and colorectal origins monitoring mice bodyweight changes, ascites …
Here, we describe a method to generate syngeneic PCa mouse models based on intraperitoneal (i.p.) administration of tumor cells. This …
Antibodies to Der p 1 and Der p 2 in allergic patients.
Cruz RH, Ynoue LH, Aranda CS, Solé D, Neto AC. Cruz RH, et al. Among authors: aranda cs. Allergol Immunopathol (Madr). 2021 Mar 1;49(2):46-52. doi: 10.15586/aei.v49i2.59. eCollection 2021. Allergol Immunopathol (Madr). 2021. PMID: 33641293
This study aimed to compare the levels of IgA, IgG, and IgE antibodies specific to Der p 1 and Der p 2 between atopic and healthy individuals. METHODS: Serum samples of 98 patients and 44 healthy controls were subjected to quantification for specific IgE, IgG, and I …
This study aimed to compare the levels of IgA, IgG, and IgE antibodies specific to Der p 1 and Der p 2 between atopic and heal …
Posttreatment prognosis of patients with esthesioneuroblastoma.
Kane AJ, Sughrue ME, Rutkowski MJ, Aranda D, Mills SA, Buencamino R, Fang S, Barani IJ, Parsa AT. Kane AJ, et al. Among authors: aranda d. J Neurosurg. 2010 Aug;113(2):340-51. doi: 10.3171/2010.2.JNS091897. J Neurosurg. 2010. PMID: 20345216 Review.
Kaplan-Meier analysis demonstrated no difference in survival between patients who underwent surgery alone and those who underwent surgery plus radiotherapy at 5 years (78 vs 75%) or 10 years (67 vs 61%, respectively) (p = 0.3). Univariate analysis demonstrated worse surviv …
Kaplan-Meier analysis demonstrated no difference in survival between patients who underwent surgery alone and those who underwent surgery pl …
The long-term postsurgical prognosis of patients with pineoblastoma.
Tate M, Sughrue ME, Rutkowski MJ, Kane AJ, Aranda D, McClinton L, McClinton L, Barani IJ, Parsa AT. Tate M, et al. Among authors: aranda d. Cancer. 2012 Jan 1;118(1):173-9. doi: 10.1002/cncr.26300. Epub 2011 Jun 29. Cancer. 2012. PMID: 21717450 Free article. Review.

The analyses demonstrated a markedly worse prognosis for children aged 5 years compared with older patients (5-year survival rate: 15% for children aged 5 years vs 57% for children aged 5 years; log-rank P < .00001). In addition, a graded increase in survival was observ

…
The analyses demonstrated a markedly worse prognosis for children aged 5 years compared with older patients (5-year survival rate: 15% for c …
Beyond audiofacial morbidity after vestibular schwannoma surgery.
Sughrue ME, Yang I, Aranda D, Rutkowski MJ, Fang S, Cheung SW, Parsa AT. Sughrue ME, et al. Among authors: aranda d. J Neurosurg. 2011 Feb;114(2):367-74. doi: 10.3171/2009.10.JNS091203. Epub 2009 Nov 27. J Neurosurg. 2011. PMID: 19943734 Review.
Neurological complications occurred in 8.6% of cases (95% CI 7.9-9.3%) and were less likely with the resection of smaller tumors (p < 0.0001) and the use of the translabyrinthine approach (p < 0.0001). ...
Neurological complications occurred in 8.6% of cases (95% CI 7.9-9.3%) and were less likely with the resection of smaller tumors (p & …
Graphics.
Aranda JM. Aranda JM. Bol Asoc Med P R. 1978 May;70(5):158-9. Bol Asoc Med P R. 1978. PMID: 278613 No abstract available.
Egg allergy and yellow fever vaccination.
Cançado BLB, Aranda CS, Mallozi MC, Weckx LY, Solé D. Cançado BLB, et al. Among authors: aranda cs. J Pediatr (Rio J). 2024 Jan-Feb;100(1):60-66. doi: 10.1016/j.jped.2023.07.004. Epub 2023 Aug 16. J Pediatr (Rio J). 2024. PMID: 37597532 Free PMC article.
There was an association between positive skin test results with YFV and the severity of the reaction (OR:7.64; 95%CI:1.61-36.32; p = 0,011). Only the presence of sIgE to ovomucoid was associated with clinical symptoms (p = 0,025). ...
There was an association between positive skin test results with YFV and the severity of the reaction (OR:7.64; 95%CI:1.61-36.32; p = …
970 results